|
PPAT expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.392200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.483800E-01 |
| Normal-vs-Stage2 |
7.018400E-01 |
| Normal-vs-Stage3 |
2.760800E-01 |
| Normal-vs-Stage4 |
6.217200E-01 |
| Stage1-vs-Stage2 |
7.678600E-01 |
| Stage1-vs-Stage3 |
1.922800E-01 |
| Stage1-vs-Stage4 |
5.221800E-01 |
| Stage2-vs-Stage3 |
2.752600E-01 |
| Stage2-vs-Stage4 |
4.936200E-01 |
| Stage3-vs-Stage4 |
6.955600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.776800E-01 |
| Normal-vs-AfricanAmerican |
7.356600E-03 |
| Normal-vs-Asian |
9.368400E-01 |
| Caucasian-vs-AfricanAmerican |
3.364900E-03 |
| Caucasian-vs-Asian |
9.569600E-01 |
| AfricanAmerican-vs-Asian |
2.786000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.479400E-01 |
| Normal-vs-Female |
9.823000E-01 |
| Male-vs-Female |
6.773200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.852780E-01 |
| Normal-vs-Age(41-60Yrs) |
8.885800E-01 |
| Normal-vs-Age(61-80Yrs) |
9.940600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.268420E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.173600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.321600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.893400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.771800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.184600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.632200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.348400E-01 |
| Normal-vs-Grade 2 |
4.954000E-01 |
| Normal-vs-Grade 3 |
2.813000E-01 |
| Normal-vs-Grade 4 |
4.558600E-01 |
| Grade 1-vs-Grade 2 |
8.220400E-01 |
| Grade 1-vs-Grade 3 |
3.288000E-01 |
| Grade 1-vs-Grade 4 |
4.316000E-01 |
| Grade 2-vs-Grade 3 |
8.114200E-02 |
| Grade 2-vs-Grade 4 |
2.309400E-01 |
| Grade 3-vs-Grade 4 |
9.461800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.927730E-02 |
| Normal-vs-ccB subtype |
1.369010E-01 |
| ccA subtype-vs-ccB subtype |
3.176800E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.337600E-01 |
| Normal-vs-N1 |
4.750400E-01 |
| N0-vs-N1 |
4.587200E-01 |
|
|
